| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/23/2005 | CN1599605A Pharmaceutical compositions and methods for administering EP2 receptor selective agonists |
| 03/23/2005 | CN1599599A Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
| 03/23/2005 | CN1599594A Solid oral compositions |
| 03/23/2005 | CN1597008A Local preparation containing poloxamer and other microbe killing agent and applicator |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193756C SGK2 and SGK3 used as diagnostic and therapeutic targets |
| 03/23/2005 | CN1193747C Diphenyl ketoaldehyde derivatives with anti-HIV activity |
| 03/22/2005 | US6871171 System and methods for optimized drug delivery and progression of diseased and normal cells |
| 03/22/2005 | US6870031 Haemopoietin receptor and genetic sequences encoding same |
| 03/22/2005 | US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 03/22/2005 | US6869970 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents |
| 03/22/2005 | US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer |
| 03/22/2005 | US6869944 Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| 03/22/2005 | US6869929 Autoimmune disease; cardiovascular disorders; rheumatic disorders |
| 03/22/2005 | US6869926 Comprises amylin/adrenomedullin which stimulates chondrocyte proliferation; for treatment of cartilage disorders/bone growth disorders |
| 03/22/2005 | US6869925 Comprises serine leukocyte protease inhibitor for treatment of HIV |
| 03/22/2005 | US6869789 Heparinase III and uses thereof |
| 03/22/2005 | US6869615 Enterically coated to prevent gastrointestinal side effects |
| 03/22/2005 | US6869610 Pain treatment by peripheral administration of a neurotoxin |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/17/2005 | WO2005023368A1 Prophylaxis of and treatment for infections from the family chlamydiaceae using amino acids as leucine or methionine |
| 03/17/2005 | WO2005023328A2 Methods for intradermal delivery of therapeutics agents |
| 03/17/2005 | WO2005023307A1 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 03/17/2005 | WO2005023305A2 Modulating cell activity by using an agent that reduces the level of cholesterol within a cell |
| 03/17/2005 | WO2005023304A2 Antimalarial compositions and manufacturing process thereof |
| 03/17/2005 | WO2005023296A1 Treatment of rheumatic diseases |
| 03/17/2005 | WO2005023286A1 Medical agent for prevention and/or treatment of alzheimer disease |
| 03/17/2005 | WO2005023283A1 Ophthalmic composition |
| 03/17/2005 | WO2005023279A1 Anti-stress composition and inhaler therefor |
| 03/17/2005 | WO2005023273A1 Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents |
| 03/17/2005 | WO2005023270A2 Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors |
| 03/17/2005 | WO2005023264A1 Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide and an lhrh analogue and/or a bisphosphonate |
| 03/17/2005 | WO2005023258A1 Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives |
| 03/17/2005 | WO2005023250A1 Use of telmisartan for the prevention of vascular headache |
| 03/17/2005 | WO2005023239A1 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases |
| 03/17/2005 | WO2005023233A2 Antimicrobial compositions and methods |
| 03/17/2005 | WO2005023190A2 Treatment for cd5+ b cell lymphoma |
| 03/17/2005 | WO2005023020A1 Composition and method for facilitating bone healing |
| 03/17/2005 | WO2005009431B1 Methods for treating inflammation and inflammation-associated diseases with a statin and ether |
| 03/17/2005 | WO2005004915A3 Compositions comprising meloxicam |
| 03/17/2005 | WO2004105703A3 Compounds, formulations, and methods for treating or preventing rosacea |
| 03/17/2005 | WO2004103408A3 Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine |
| 03/17/2005 | WO2004082669A3 Antiflatulents in combibation with histamine h1-receptor antagonist for treating gastrointestinal disoders |
| 03/17/2005 | WO2004060291A3 Uses of mammalian cytokine; related reagents |
| 03/17/2005 | WO2004045612A8 Use of a proton pump inhibitor for preventing postoperative nausea and vomiting |
| 03/17/2005 | WO2004041154A3 Abuse-resistant opioid dosage form |
| 03/17/2005 | WO2003043619A8 New use for the treatment of gastroesophageal reflux disease |
| 03/17/2005 | WO2003039578A8 Treatment of congestive heart failure |
| 03/17/2005 | US20050059956 Devices for intraocular drug delivery |
| 03/17/2005 | US20050059914 Massage appliance |
| 03/17/2005 | US20050059745 Treating drug resistance viral infections such as HIV using a sulfide, sulfone, sulfonyl or sulfonate-functional benzene compound of given formula that inactivate transcription factors such as nuclear factor kappa beta (NF-kb) |
| 03/17/2005 | US20050059744 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 03/17/2005 | US20050059742 Such as 5-butyl-2,4-dihydro-4-[[2'-[N-(3-chloro-2-thiophenecarbonyl)sulfamoyl]biphenyl-4-yl]methyl]-2-{2-(trifluoromethyl)phenyl]-1,2,4-triazol-3-one potassium salt, or a prostaglandin derivative, or 6-Isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809) |
| 03/17/2005 | US20050059741 Compositions and methods involving the combination of a thromboxane A2 receptor antagonist and an inhibitor of cyclooxygenase-1 |
| 03/17/2005 | US20050059734 Compositions comprising inhibitors of IMPDH enzyme |
| 03/17/2005 | US20050059720 Medicinal compositions for the prevention or treatment of cardiac failure |
| 03/17/2005 | US20050059718 Improve the safety anti-epilepsy therapy, reducing the side effect of drug, by informing and monitoring the patient by laboratory test, medical evaluation; adjusting the dosages |
| 03/17/2005 | US20050059715 Treatment of pain, particularly neuropathic pain; with serotonin re-uptake inhibitor (gabapentin), serotonin re-uptake inhibitor (sertraline, fluoxetine), noradrenaline re-uptake inhibitor (reboxetine) or serotonin-noradrenaline re-uptake inhibitor (venlafaxine) |
| 03/17/2005 | US20050059704 5-HT3 agonist is selecting from (R) N-1-azabicyclo[2.2.2]oct-3-yl-4,7-dihydro-7-oxothieno[3,2-b]pyridine-6-carboxamide or 2-(1H-imidazol-4-ylmethyl)-8H-indeno[1,2-d]thiazole; proton pump inhibitor, an H2 receptor antagonist; increasing esophageal motility |
| 03/17/2005 | US20050059703 Diaryl ureas for diseases mediated by PDGFR |
| 03/17/2005 | US20050059697 Combination of organic compounds |
| 03/17/2005 | US20050059693 Heterocyclic thioester and ketone hair growth compositions and uses |
| 03/17/2005 | US20050059688 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059665 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 03/17/2005 | US20050059660 Novel combination |
| 03/17/2005 | US20050059657 Aminoisoxazole derivatives active as kinase inhibitors |
| 03/17/2005 | US20050059654 Method for treatment of depression and anxiety disorders by combination therapy |
| 03/17/2005 | US20050059647 Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus |
| 03/17/2005 | US20050059644 Including one or more anesthetic agents and/or one or more anti-inflammatory agents and/or a combination of ammonium, sodium, and potassium salts, preferably of an alpha-hydroxy acid |
| 03/17/2005 | US20050059641 Comprising an analog of 1,25(OH)2D3, such as 1,25(OH)2D3-3-BE or 25(OH)2D3-3-BE, wherein said analog is alkylated or acylated; for the treatment of prostate cancer and metabolic diseases, such as psoriasis |
| 03/17/2005 | US20050059634 Compositions, and methods that inhibit the formation and/or activity of Alzheimer's disease diffusible ligands(ADDLs), and, consequently, are useful in the treatment of Alzheimer's disease and other diseases and conditions associated with ADDLs |
| 03/17/2005 | US20050059625 Immunostimulatory nucleic acid molecules |
| 03/17/2005 | US20050059609 New alpha crystalline form of perindopril tert-butylamine salt |
| 03/17/2005 | US20050059606 hexapeptides including enantiomers, stereoisomers and tautomers, used as enzyme inhibitors for prophylaxis or prevention of viral diseases |
| 03/17/2005 | US20050059601 by administering an exendin peptide analog of given amino acid sequence; treating Type II diabetes, eating disorders, and insulin-resistance syndrome |
| 03/17/2005 | US20050059594 Administering macrophage derived factor; oncomodulin |
| 03/17/2005 | US20050059586 For increasing expression of human presenilin; for treatment of neurodegenerative diseases, Alzheimer's disease; drug screening |
| 03/17/2005 | US20050059151 Compositions and methods for priming monocytic dendritic cells and t cells for th-1response |
| 03/17/2005 | US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents |
| 03/17/2005 | US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059092 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 03/17/2005 | US20050059081 Dipeptidyl peptidase IV (DPPIV); homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders; antibodies for therapeutic or diagnostic use; host cells |
| 03/17/2005 | US20050059067 Using restriction fragment length polymorphism in tyrosine kinase varian t as diagnostic tool in detection of cell proliferative and inflammatory disorders |
| 03/17/2005 | US20050059008 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 03/17/2005 | US20050058999 Gene involved in apoptosis regulation |
| 03/17/2005 | US20050058983 Immunoglobulin which specifically binds to lymphadenopathy associated viral glycoprotein 120 for use as tool in prevention and treatment of viral infection; immunotherapy |
| 03/17/2005 | US20050058734 Relieving pain by injecting or infiltrating implantable dose of a capsaicinoid to denervate and vasoconstrictor; cancer, trauma, headache, diabetes, arthritic and/or neuropathic pain; local anesthetics |
| 03/17/2005 | US20050058730 Dry powdered extract from medicinal herbs mixed with vitamins, minerals, sheep liver and/or carrot root; health foods, cakes, candy, bread, chocolate |
| 03/17/2005 | US20050058725 Gelatinase inhibitors; anticancer agents |
| 03/17/2005 | US20050058720 Administering thiomolybdate to bind copper and form tripartite complex with protein; ocular, corneal or retinal/choroidal neovascularization, glaucoma, diabetes, delayed wound healing, burns, Osler-Weber Syndrome, psoriasis, parasitic diseases or atherosclerosis; antitumor and anticarcinogenic agents |
| 03/17/2005 | US20050058708 Antibiotic product, use and formulation thereof |
| 03/17/2005 | US20050058696 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 03/17/2005 | US20050058673 Decontamination of vegetables, meats or fruits by disinfection of such with antimicrobial solution containing lipid and enhancer such as bacteriocins, sugars and enzymes |
| 03/17/2005 | US20050058672 Baby Care Skin Protectant Compositions for Diaper Rash |
| 03/17/2005 | US20050058671 synergistic efficacy; polar lipid supplement which contains significant amounts of polar lipids and antioxidants; soluble beta-glucan fiber; and amino acid such as L-threonine |
| 03/17/2005 | US20050058666 Method for treating pain by peripheral administration of a neuroptoxin |
| 03/17/2005 | US20050058641 Tolerance induction and maintenance in hematopoietic stem cell allografts |
| 03/17/2005 | US20050058623 Use of gp130 activators in diabetic neuropathy |